CategoriesPaper Científicos septiembre 27, 2016 Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy Ariel R. Guerrero1, Felipe Oyarzun-Ampuero, Natalia Hassan, Alejandro H. Corvalán, Andrew F.G. Quest and Marcelo J. Kogan Navegación de entradasPrevious post miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Next post The case for aflatoxins in the causal chain of gallbladder cancer